Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021

Table 5 The association of breadth of malaria antigen recognition and demographic and clinical data

Characteristic	N	Crude OR (95% CI)	p-value	Overall p-value	Adjusted OR (95% CI)	p-value	Overall p-value
Age of participants							0.001
Age in years	501	1.16 (1.12–1.20)	0.001		1.12 (1.08–1.16)	0.001
Village of residence
Mkokola	234	Ref	Ref		Ref
Kwamasimba	267	1.88 (1.35–2.60)	0.001		1.91 (1.34–2.71)	0.001
Bed net use
Yes	480	Ref	Ref		Ref
No	19	3.95 (1.64–9.51)	0.002		2.27 (0.87–5.88)	0.09
Fever
Yes	111	Ref	Ref		Ref
No	389	0.45 (0.31–0.68)	0.001		0.41 (0.25–0.67)	0.001
Cough
Yes	170	Ref	Ref		Ref
No	330	1.26 (0.90)	0.18		1.20 (0.83–1.74)	0.32
Body weakness
Yes	19	Ref	Ref	Ref	Ref
No	452	0.39 (0.17–0.89)	0.03	0.001	1.00 (0.36–2.80)	1.00
NA	29	0.06 (0.02–017)	0.001	0.001	1.27 (0.0–18.54)	0.86
Headache
Yes	110	Ref	Ref	Ref	Ref
No	360	0.40 (0.27–0.59)	0.001	0.001	0.65 (0.40–1.07)	0.09
NA	30	0.05 (0.02–0.12)	0.001	0.001	0.06 (0.01–0.46)	0.01
Body pain
Yes	20	Ref	Ref	Ref	Ref
No	444	0.60 (0.60–0.26)	0.21		2.83 (1.03–7.75)	0.04
NA	34	0.10 (0.03–0.27)	0.001		4.35 (0.50–37.61)	0.18
Abdominal pain
Yes	99	Ref	Ref	Ref	Ref
No	368	0.69 (0.46–1.04)	0.08		0.85 (0.55–1.33)	0.48
NA	32	0.10 (0.05–0.23)	0.001		1.63 (0.25–10.78)	0.61
Loss of appetite
Yes	23	Ref	Ref	Ref	Ref
No	452	0.37 (0.17–0.80)	0.01		0.67 (0.28–1.56)	0.35
NA	25	0.05 (0.02–0.16)	0.001		0.53 (0.06–4.93)	0.58

ISSN: 1471-2334